Table 3.
Outcomes | Study type | No. of studies | Events/Total | RR, 95%CI, P | Test of Heterogeneity | Tests of Publication Bias | |||
---|---|---|---|---|---|---|---|---|---|
Closed | Open | Random | I2 (%) | P | Begg’s P | Egger’s P | |||
Cryosurvival rate | Prospective | 4 | 621/724 | 803/895 | 0.98, [0.96, 1.01], 0.29 | 0% | 0.42 | 0.734 | 0.612 |
Retrospective | 3 | 770/805 | 959/1013 | 1.00, [0.97, 1.03], 0.88 | 58% | 0.09 | 1.000 | 0.940 | |
Positive βHCG rate | Prospective | 2 | 115/222 | 114/211 | 0.96, [0.80, 1.14], 0.64 | 0% | 0.77 | 1.000 | NA |
Implantation rate | Prospective | 3 | 160/535 | 196/590 | 0.98, [0.83, 1.15], 0.80 | 0% | 0.93 | 1.000 | 0.798 |
Retrospective | 4 | 333/839 | 444/1071 | 0.97, [0.81, 1.17], 0.76 | 53% | 0.09 | 0.308 | 0.805 | |
Cancellation rate | Retrospective | 2 | 9/321 | 9/267 | 0.75, [0.18, 3.04], 0.69 | 30% | 0.23 | 1.000 | NA |
Clinical pregnancy rate | Prospective | 3 | 134/304 | 226/432 | 0.89, [0.76, 1.05], 0.17 | 0% | 0.91 | 1.000 | 0.613 |
Retrospective | 4 | 280/513 | 374/577 | 0.96, [0.79, 1.17], 0.69 | 61% | 0.05 | 0.734 | 0.790 | |
Ongoing pregnancy rate | Prospective | 3 | 133/319 | 160/369 | 0.98, [0.82, 1.16], 0.79 | 0% | 1.00 | 1.000 | 0.682 |
Retrospective | 2 | 114/312 | 105/258 | 0.96, [0.71, 1.29], 0.77 | 50% | 0.16 | 1.000 | NA | |
Miscarriage rate | Prospective | 2 | 4/93 | 8/94 | 0.60, [0.11, 3.31], 0.56 | 43% | 0.18 | 1.000 | NA |
Retrospective | 3 | 61/276 | 76/360 | 1.07 [0.79, 1.46], 0.66 | 0% | 0.71 | 1.000 | 0.337 | |
Live birth rate | Prospective | 2 | 123/287 | 193/415 | 0.96, [0.81, 1.15], 0.69 | 0% | 0.71 | 1.000 | NA |
Retrospective | 4 | 217/513 | 313/577 | 0.88 [0.71, 1.10], 0.26 | 48% | 0.12 | 0.308 | 0.163 | |
Babies born/ transferred blastocysts | Retrospective | 2 | 114/438 | 124/420 | 0.82 [0.65, 1.02], 0.09 | 0% | 0.48 | 1.000 | NA |
Multiple birth rate | Retrospective | 3 | 30/293 | 21/357 | 0.95 [0.41, 2.24], 0.92 | 52% | 0.13 | 1.000 | 0.831 |
NA not applicable, RR risk ratio